 | • レポートコード：GIR201102287 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、セツキシマブの世界市場を調査対象にし、セツキシマブの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（100mg/50mL注射、200mg/100mL注射）、用途別分析（頭頸部がん、転移性大腸がん）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Eli Lilly、Merck ・メーカー別販売量、売上、市場シェア ・セツキシマブの地域別市場分析 ・セツキシマブの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・セツキシマブのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・セツキシマブのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・セツキシマブの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・セツキシマブの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・セツキシマブの種類別市場規模2015-2020：100mg/50mL注射、200mg/100mL注射 ・セツキシマブの用途別市場規模2015-2020：頭頸部がん、転移性大腸がん ・セツキシマブの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Cetuximab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cetuximab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cetuximab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cetuximab market has been segmented into
100 mg/50 mL Injection
200 mg/100 mL Injection
By Application, Cetuximab has been segmented into:
Head and Neck Cancer
Metastatic Colorectal Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cetuximab market presented in the report. This section sheds light on the sales growth of different regional and country-level Cetuximab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cetuximab market.
The report offers in-depth assessment of the growth and other aspects of the Cetuximab market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cetuximab Market Share Analysis
Cetuximab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cetuximab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cetuximab sales, revenue and market share for each player covered in this report.
The major players covered in Cetuximab are:
Eli Lilly
Merck
Among other players domestic and global, Cetuximab market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cetuximab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cetuximab, with price, sales, revenue and global market share of Cetuximab in 2018 and 2019.
Chapter 3, the Cetuximab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cetuximab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cetuximab market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cetuximab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cetuximab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cetuximab Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 100 mg/50 mL Injection
1.2.3 200 mg/100 mL Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Cetuximab Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Head and Neck Cancer
1.3.3 Metastatic Colorectal Cancer
1.4 Overview of Global Cetuximab Market
1.4.1 Global Cetuximab Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Cetuximab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Cetuximab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cetuximab Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cetuximab Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cetuximab Manufacturer Market Share in 2019
3.3.2 Top 6 Cetuximab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cetuximab Sales, Revenue and Market Share by Regions
4.1.1 Global Cetuximab Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cetuximab Revenue and Market Share by Regions (2015-2020)
4.2 North America Cetuximab Sales and Growth Rate (2015-2020)
4.3 Europe Cetuximab Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cetuximab Sales and Growth Rate (2015-2020)
4.5 South America Cetuximab Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cetuximab Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cetuximab Sales, Revenue and Market Share by Country
5.1.1 North America Cetuximab Sales and Market Share by Country (2015-2020)
5.1.2 North America Cetuximab Revenue and Market Share by Country (2015-2020)
5.2 United States Cetuximab Sales and Growth Rate (2015-2020)
5.3 Canada Cetuximab Sales and Growth Rate (2015-2020)
5.4 Mexico Cetuximab Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cetuximab Sales, Revenue and Market Share by Country
6.1.1 Europe Cetuximab Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cetuximab Revenue and Market Share by Country (2015-2020)
6.2 Germany Cetuximab Sales and Growth Rate (2015-2020)
6.3 UK Cetuximab Sales and Growth Rate (2015-2020)
6.4 France Cetuximab Sales and Growth Rate (2015-2020)
6.5 Russia Cetuximab Sales and Growth Rate (2015-2020)
6.6 Italy Cetuximab Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cetuximab Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cetuximab Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cetuximab Revenue and Market Share by Regions (2015-2020)
7.2 China Cetuximab Sales and Growth Rate (2015-2020)
7.3 Japan Cetuximab Sales and Growth Rate (2015-2020)
7.4 Korea Cetuximab Sales and Growth Rate (2015-2020)
7.5 India Cetuximab Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cetuximab Sales and Growth Rate (2015-2020)
7.7 Australia Cetuximab Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cetuximab Sales, Revenue and Market Share by Country
8.1.1 South America Cetuximab Sales and Market Share by Country (2015-2020)
8.1.2 South America Cetuximab Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cetuximab Sales and Growth Rate (2015-2020)
8.3 Argentina Cetuximab Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cetuximab Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cetuximab Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cetuximab Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cetuximab Sales and Growth Rate (2015-2020)
9.3 Turkey Cetuximab Sales and Growth Rate (2015-2020)
9.4 Egypt Cetuximab Sales and Growth Rate (2015-2020)
9.5 South Africa Cetuximab Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cetuximab Sales and Market Share by Type (2015-2020)
10.2 Global Cetuximab Revenue and Market Share by Type (2015-2020)
10.3 Global Cetuximab Price by Type (2015-2020)
11 Global Cetuximab Market Segment by Application
11.1 Global Cetuximab Sales Market Share by Application (2015-2020)
11.2 Global Cetuximab Revenue Market Share by Application (2015-2020)
11.3 Global Cetuximab Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cetuximab Sales, Revenue and Growth Rate (2021-2025)
12.2 Cetuximab Market Forecast by Regions (2021-2025)
12.2.1 North America Cetuximab Market Forecast (2021-2025)
12.2.2 Europe Cetuximab Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cetuximab Market Forecast (2021-2025)
12.2.4 South America Cetuximab Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cetuximab Market Forecast (2021-2025)
12.3 Cetuximab Market Forecast by Type (2021-2025)
12.3.1 Global Cetuximab Sales Forecast by Type (2021-2025)
12.3.2 Global Cetuximab Market Share Forecast by Type (2021-2025)
12.4 Cetuximab Market Forecast by Application (2021-2025)
12.4.1 Global Cetuximab Sales Forecast by Application (2021-2025)
12.4.2 Global Cetuximab Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cetuximab Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cetuximab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cetuximab Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Cetuximab Major Business
Table 9. Eli Lilly Cetuximab Total Revenue (USD Million) (2018-2019)
Table 10. Eli Lilly SWOT Analysis
Table 11. Eli Lilly Cetuximab Product and Services
Table 12. Eli Lilly Cetuximab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Cetuximab Major Business
Table 15. Merck Cetuximab Total Revenue (USD Million) (2018-2019)
Table 16. Merck SWOT Analysis
Table 17. Merck Cetuximab Product and Services
Table 18. Merck Cetuximab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Cetuximab Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Cetuximab Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Cetuximab Sales by Regions (2015-2020) (K Units)
Table 22. Global Cetuximab Sales Market Share by Regions (2015-2020)
Table 23. Global Cetuximab Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Cetuximab Sales by Countries (2015-2020) (K Units)
Table 25. North America Cetuximab Sales Market Share by Countries (2015-2020)
Table 26. North America Cetuximab Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Cetuximab Revenue Market Share by Countries (2015-2020)
Table 28. Europe Cetuximab Sales by Countries (2015-2020) (K Units)
Table 29. Europe Cetuximab Sales Market Share by Countries (2015-2020)
Table 30. Europe Cetuximab Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Cetuximab Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Cetuximab Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Cetuximab Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Cetuximab Sales by Countries (2015-2020) (K Units)
Table 35. South America Cetuximab Sales Market Share by Countries (2015-2020)
Table 36. South America Cetuximab Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Cetuximab Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Cetuximab Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Cetuximab Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Cetuximab Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Cetuximab Revenue Market Share by Countries (2015-2020)
Table 42. Global Cetuximab Sales by Type (2015-2020) (K Units)
Table 43. Global Cetuximab Sales Share by Type (2015-2020)
Table 44. Global Cetuximab Revenue by Type (2015-2020) (USD Million)
Table 45. Global Cetuximab Revenue Share by Type (2015-2020)
Table 46. Global Cetuximab Sales by Application (2015-2020) (K Units)
Table 47. Global Cetuximab Sales Share by Application (2015-2020)
Table 48. Global Cetuximab Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Cetuximab Market Share Forecast by Regions (2021-2025)
Table 50. Global Cetuximab Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Cetuximab Market Share Forecast by Type (2021-2025)
Table 52. Global Cetuximab Sales Forecast by Application (2021-2025)
Table 53. Global Cetuximab Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cetuximab Picture
Figure 2. Global Sales Market Share of Cetuximab by Type in 2019
Figure 3. 100 mg/50 mL Injection Picture
Figure 4. 200 mg/100 mL Injection Picture
Figure 5. Cetuximab Sales Market Share by Application in 2018
Figure 6. Head and Neck Cancer Picture
Figure 7. Metastatic Colorectal Cancer Picture
Figure 8. Global Cetuximab Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Cetuximab Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Cetuximab Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Cetuximab Sales Market Share by Manufacturer in 2019
Figure 29. Global Cetuximab Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Cetuximab Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Cetuximab Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Cetuximab Revenue Market Share by Regions (2015-2020)
Figure 36. Global Cetuximab Revenue Market Share by Regions in 2018
Figure 37. North America Cetuximab Sales and Growth Rate (2015-2020)
Figure 38. Europe Cetuximab Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Cetuximab Sales and Growth Rate (2015-2020)
Figure 40. South America Cetuximab Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Cetuximab Sales and Growth Rate (2015-2020)
Figure 42. North America Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Cetuximab Sales Market Share by Countries (2015-2020)
Figure 44. North America Cetuximab Sales Market Share by Countries in 2018
Figure 45. North America Cetuximab Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Cetuximab Revenue Market Share by Countries in 2018
Figure 47. United States Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Cetuximab Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Cetuximab Revenue Market Share by Countries in 2019
Figure 53. Germany Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Cetuximab Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Cetuximab Revenue Market Share by Regions 2019
Figure 61. China Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Cetuximab Sales Market Share by Countries in 2019
Figure 68. South America Cetuximab Revenue Market Share by Countries in 2019
Figure 69. Brazil Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Cetuximab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Cetuximab Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Cetuximab Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Cetuximab Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Cetuximab Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Cetuximab Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Cetuximab Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Cetuximab Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Cetuximab Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Cetuximab Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Cetuximab Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Cetuximab Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
大腸がん分子診断の世界市場 2020年 Market Overview The global Colorectal Cancer Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Color…- 体外大腸がんスクリーニング検査の世界市場 2020年 Market Overview The global In-Vitro Colorectal Cancer Screening Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1185 million by 2025, from USD 964.8 million in 2019. …
- 転移性卵巣がん治療薬の世界市場 2020年 Market Overview The global Metastatic Ovarian Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic Ova…
- パクリタキセル注射の世界市場 2020年 Market Overview The Paclitaxel Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 頭頸部扁平上皮がん治療の世界市場 2020年 Market Overview The global Head And Neck Squamous Cell Carcinoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…